Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial
about
Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@ast
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@en
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@nl
type
label
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@ast
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@en
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@nl
prefLabel
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@ast
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@en
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@nl
P2093
P2860
P3181
P1433
P1476
Efficacy and Safety of Once-Da ...... A Randomized Controlled Trial
@en
P2093
Ajay Kumar
Edward Franek
Henriette Mersebach
Jonathan Wise
Marcus Niemeyer
Rafael Simó
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0163350
P407
P577
2016-01-01T00:00:00Z